• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pathobiology . Autopsy Findings in 32 Patients with COVID-19: A Single-Institution Experience

tetano

Editor, Senior Moderator
Pathobiology


. 2020 Sep 17;1-13.
doi: 10.1159/000511325. Online ahead of print.
Autopsy Findings in 32 Patients with COVID-19: A Single-Institution Experience


Sarah S Elsoukkary[SUP] 1 [/SUP], Maria Mostyka[SUP] 1 [/SUP], Alicia Dillard[SUP] 1 [/SUP], Diana R Berman[SUP] 1 [/SUP], Lucy X Ma[SUP] 1 [/SUP], Amy Chadburn[SUP] 2 [/SUP], Rhonda K Yantiss[SUP] 2 [/SUP], Jose Jessurun[SUP] 2 [/SUP], Surya V Seshan[SUP] 2 [/SUP], Alain C Borczuk[SUP] 2 [/SUP], Steven P Salvatore[SUP] 3 [/SUP]



Affiliations

Abstract

Background: A novel coronavirus, SARS-CoV-2, was identified in Wuhan, China in late 2019. This virus rapidly spread around the world causing disease ranging from minimal symptoms to severe pneumonia, which was termed coronavirus disease (i.e., COVID). Postmortem examination is a valuable tool for studying the pathobiology of this new infection.
Methods: We report the clinicopathologic findings from 32 autopsy studies conducted on patients who died of COVID-19 including routine gross and microscopic examination with applicable special and immunohistochemical staining techniques.
Results: SARS-CoV-2 infection was confirmed by nasopharyngeal RT-PCR in 31 cases (97%) and by immunohistochemical staining for SARS-CoV-2 spike-protein in the lung in the remaining 1 case (3%). The ethnically diverse cohort consisted of 22 males and 10 females with a mean age of 68 years (range: 30-100). Patients most commonly presented with cough (17 [55%]), shortness of breath (26 [81%]), and a low-grade fever (17 [55%]). Thirty-one (97%) of the patients had at least 1 comorbidity (mean = 4). Twenty-eight patients (88%) had widespread thromboembolic disease, as well as diffuse alveolar damage (30 [94%]), diabetic nephropathy (17 [57%]) and acute tubular injury. Patterns of liver injury were heterogeneous, featuring 10 (36%) with frequent large basophilic structures in sinusoidal endothelium, and increased immunoblast-like cells in lymph nodes.
Conclusion: This series of autopsies from patients with COVID-19 confirms the observation that the majority of severely affected patients have significant pulmonary pathology. However, many patients also have widespread microscopic thromboses, as well as characteristic findings in the liver and lymph nodes.

Keywords: Acute respiratory distress syndrome; Autopsy; COVID-19; Thrombi.
 
Back
Top Bottom